nani treatment for heavy bleeding during periods.
Phase 2
- Conditions
- Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract
- Registration Number
- CTRI/2019/02/017722
- Lead Sponsor
- ational institue of Unani medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients in age group of 18-45 yrs with regular cycles (21-35 days) with MBL > 80 ml for 2 out of 3 consecutive cycles,Patients with PBAC score >100 & endometrial thickness upto18 mm,
Patients with pelvic pathology (Polyp, uterine fibroid, adenomyosis)
Exclusion Criteria
Patients with
Systemic (HTN,DM) & endocrine diseases (thyroid dysfunction),Bleeding disorders,severe anemia (Hb <7gm%), malignancy, H/O hormonal contraceptives in last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response in <br/ ><br>MBL(PBAC score)30-50% <br/ ><br>duration of bleeding 30-50% <br/ ><br>Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method Improvement in Hb % and QOLTimepoint: 3 months